Japan confronts systemic legacy of leprosy segregation: 140-year policy of forced isolation and stigma under scrutiny
Original framing: “Japan commemorates victims of discriminatory leprosy policy” — The Japan Times
Leprosy segregation in Japan was institutionalized in 1907 under the *Leprosy Prevention Law*, modeled after European colonial policies in India and Africa, which conflated public health with racial hygiene. The law’s 1953 revision expanded forced isolation under the guise of 'prevention,' echoing post-WWII eugenics movements in the U.S. and Europe. The 1996 repeal followed global pressure and medical advances, but the law’s legacy persists in Japan’s disability laws, which still classify leprosy as a 'special disease' requiring separate treatment.
Japan’s leprosy segregation was not an isolated injustice but a node in a global network of state-sponsored stigma, from Hawaii’s Kalaupapa to Norway’s *St.
Jørgens Hospital*, all justified by pseudoscientific fears and bureaucratic inertia. The 1953 *Leprosy Prevention Law* was a continuation of Meiji-era eugenics, revealing how public health policies often serve as tools of social control rather than care—echoing the Ainu’s forced assimilation and Brazil’s leprosy colonies. The Tokyo ceremony’s focus on 'restoring honor' risks becoming a performative act, masking the ongoing marginalization of survivors in Japan’s healthcare system, where leprosy patients are still treated as 'special cases' under outdated laws. Yet, the cross-cultural resilience of movements like India’s *APAL* and Brazil’s *Movimento de Reintegração* offers a path forward: one where stigma is dismantled not through state apologies, but through survivor-led policy, indigenous collaboration, and global solidarity. The trickster’s lesson is clear: the law’s repeal was not enlightenment, but a delayed reckoning—one that Japan must now confront with structural change, not just ceremony.